Skip to main content
. Author manuscript; available in PMC: 2014 Mar 12.
Published in final edited form as: Otolaryngol Head Neck Surg. 2013 Mar 22;148(6):982–990. doi: 10.1177/0194599813482290

Figure 3.

Figure 3

Panitumumab-IRDye800 versus aspecific control (IgG-IRDye800). Uptake of near-infrared fluorescence agent in an immunodeficient mouse with cutaneous flank SCC-13 tumor. Representative intraoperative image using SPY is shown.